Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Pro-MMP-9 upregulation in HT1080 cells expressing CD9 is regulated by epidermal growth factor receptor.

Herr MJ, Mabry SE, Jameson JF, Jennings LK.

Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):99-104. doi: 10.1016/j.bbrc.2013.11.021. Epub 2013 Nov 16.

2.

Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.

Herr MJ, Kotha J, Hagedorn N, Smith B, Jennings LK.

PLoS One. 2013 Jun 28;8(6):e67766. doi: 10.1371/journal.pone.0067766. Print 2013.

3.

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

Farabegoli F, Papi A, Orlandi M.

Biosci Rep. 2011 Apr;31(2):99-108. doi: 10.1042/BSR20090143.

PMID:
20446926
4.

Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.

Dong QZ, Wang Y, Tang ZP, Fu L, Li QC, Wang ED, Wang EH.

Am J Pathol. 2013 Mar;182(3):954-64. doi: 10.1016/j.ajpath.2012.11.019. Epub 2013 Jan 7.

PMID:
23306155
5.

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.

Cancer Res. 2000 Feb 15;60(4):1121-8.

6.
8.

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.

Alper O, Bergmann-Leitner ES, Bennett TA, Hacker NF, Stromberg K, Stetler-Stevenson WG.

J Natl Cancer Inst. 2001 Sep 19;93(18):1375-84.

PMID:
11562388
9.

Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.

Ellerbroek SM, Halbleib JM, Benavidez M, Warmka JK, Wattenberg EV, Stack MS, Hudson LG.

Cancer Res. 2001 Mar 1;61(5):1855-61.

10.

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.

Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS.

Oncol Rep. 2012 Nov;28(5):1799-807. doi: 10.3892/or.2012.1991. Epub 2012 Aug 24.

PMID:
22923287
11.

Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.

Chun J, Kim YS.

Chem Biol Interact. 2013 Oct 5;205(3):212-21. doi: 10.1016/j.cbi.2013.07.002. Epub 2013 Jul 16.

PMID:
23867902
12.

Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells.

Chen HJ, Jiang YL, Lin CM, Tsai SC, Peng SF, Fushiya S, Hour MJ, Yang JS.

Int J Oncol. 2013 Jul;43(1):141-50. doi: 10.3892/ijo.2013.1941. Epub 2013 May 16.

PMID:
23677180
13.

CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling.

Wang GP, Han XF.

Mol Med Rep. 2015 Jul;12(1):1381-6. doi: 10.3892/mmr.2015.3466. Epub 2015 Mar 10.

PMID:
25760022
14.

CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.

Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L.

Mol Cancer Res. 2011 Feb;9(2):161-72. doi: 10.1158/1541-7786.MCR-10-0386. Epub 2011 Jan 4.

15.
16.

Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.

Hwang HJ, Park HJ, Chung HJ, Min HY, Park EJ, Hong JY, Lee SK.

J Nutr Biochem. 2006 May;17(5):356-62. Epub 2005 Sep 19.

PMID:
16214327
17.

LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells.

Tapia T, Ottman R, Chakrabarti R.

Mol Cancer. 2011 Jan 10;10:6. doi: 10.1186/1476-4598-10-6.

18.

Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.

Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y, Xiao ZQ.

J Cell Biochem. 2011 Sep;112(9):2508-17. doi: 10.1002/jcb.23175.

PMID:
21557297
19.

Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.

Yodkeeree S, Garbisa S, Limtrakul P.

Acta Pharmacol Sin. 2008 Jul;29(7):853-60. doi: 10.1111/j.1745-7254.2008.00792.x.

20.

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.

Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M.

Clin Cancer Res. 2004 Dec 15;10(24):8243-9.

Supplemental Content

Support Center